PE firm Ampersand acquires German CDMO Vibalogics
The private equity firm Ampersand Capital has acquired Vibalogics with plans to increase development and manufacturing capabilities for complex viral products.
Archives for June 3, 2019
How to solve the cell and gene therapy skill gap?
In the UK alone, the numbers of employees entering the cell and gene therapy manufacturing space needs to double in the next five years, eXmoor’s MD suggested.